Abstract
Background: Developing early detection diagnostic methods, especially non-invasive methods, is a critical component in raising the overall survival rate and prognosis for lung cancer (LC) patients. Recently, we described a novel Liquid ImmunoBiopsy™ test to detect early stage LC with high accuracy. As a part of our ongoing clinical trials for early detection of LC, a blood specimen was received from a ‘healthy’ volunteer, nonsmoker male, who was recruited as a part of the trial’s control group. The Liquid ImmunoBiopsy™ test result of this subject clearly indicated a lung-related malignant lesion. The objective of this article is to provide a detailed description of the subsequent investigation of this case, up to the surgical intervention.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
